Cargando…

Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review

BACKGROUND: Psychiatric disorders increase risk of neuropsychiatric disease and poor outcomes, yet little is known about the neuropsychiatric manifestations of COVID-19 in the psychiatric population. The primary objective is to synthesize neuropsychiatric outcomes of COVID-19 in people with preexist...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Reekum, Emma A., Rosic, Tea, Sergeant, Anjali, Sanger, Nitika, Rodrigues, Myanca, Rebinsky, Reid, Panesar, Balpreet, Deck, Eve, Kim, Nayeon, Woo, Julia, D’Elia, Alessia, Hillmer, Alannah, Dufort, Alexander, Sanger, Stephanie, Thabane, Lehana, Mbuagbaw, Lawrence, Samaan, Zainab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667019/ https://www.ncbi.nlm.nih.gov/pubmed/34903299 http://dx.doi.org/10.1186/s13256-021-03140-6

Ejemplares similares

The Role of Perceived Social Support in the Association Between Stressful Life Events and Suicidal Behavior
por: Panesar, Balpreet, et al.
Publicado: (2021)

Identifying patient-important outcomes for treatment of bipolar disorder: a systematic review protocol
por: D'Elia, Alessia, et al.
Publicado: (2021)

Impact of COVID-19 and other pandemics and epidemics on people with pre-existing mental disorders: a systematic review protocol and suggestions for clinical care
por: Sergeant, Anjali, et al.
Publicado: (2020)

Outcomes reported in randomised controlled trials of major depressive disorder in older adults: protocol for a methodological review
por: Rodrigues, Myanca, et al.
Publicado: (2021)

The Inclusion of Patients’ Reported Outcomes to Inform Treatment Effectiveness Measures in Opioid Use Disorder. A Systematic Review
por: Sanger, Nitika, et al.
Publicado: (2022)

Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder
por: Chai, Darren, et al.
Publicado: (2021)

Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada
por: Rosic, Tea, et al.
Publicado: (2021)

The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials
por: Sanger, Nitika, et al.
Publicado: (2020)

Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?
por: Au, Vivian Y. O., et al.
Publicado: (2021)

The association between cannabis use and outcome in pharmacological treatment for opioid use disorder
por: Rosic, Tea, et al.
Publicado: (2021)

Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data
por: Naji, Leen, et al.
Publicado: (2022)

Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
por: van Reekum, Emma A., et al.
Publicado: (2020)

Are patients’ goals in treatment associated with expected treatment outcomes? Findings from a mixed-methods study on outpatient pharmacological treatment for opioid use disorder
por: Rosic, Tea, et al.
Publicado: (2021)

Factors affecting participant recruitment and retention in borderline personality disorder research: a feasibility study
por: Woo, Julia, et al.
Publicado: (2021)

Corrigendum to ‘A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis’ [EClinicalMedicine 24 (2020) 100442]
por: Sanger, Nitika, et al.
Publicado: (2021)

Association between vaping and health outcomes in patients with opioid use disorder: a systematic review protocol
por: Sanger, Nitika, et al.
Publicado: (2021)

The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder
por: Naji, Leen, et al.
Publicado: (2021)

Psychosis and Comorbid Opioid Use Disorder: Characteristics and Outcomes in Opioid Substitution Therapy
por: Lamont, Rachel, et al.
Publicado: (2020)

Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis
por: Sanger, Nitika, et al.
Publicado: (2020)

The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences
por: Naji, Leen, et al.
Publicado: (2018)

GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol
por: Chawar, Caroul, et al.
Publicado: (2020)

A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder
por: Chawar, Caroul, et al.
Publicado: (2021)

The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment
por: Shams, Ieta, et al.
Publicado: (2019)

Genetic basis of cannabis use: a systematic review
por: Hillmer, Alannah, et al.
Publicado: (2021)

National suicide management guidelines recommending family-based prevention, intervention and postvention and their association with suicide mortality rates: systematic review
por: Panesar, Balpreet, et al.
Publicado: (2022)

Genetic determinants of cannabis use: a systematic review protocol
por: Hillmer, Alannah, et al.
Publicado: (2020)

Investigating and addressing the immediate and long-term consequences of the COVID-19 pandemic on patients with substance use disorders: a scoping review and evidence map protocol
por: Naji, Leen, et al.
Publicado: (2021)

Exploring psychological symptoms and associated factors in patients receiving medication-assisted treatment for opioid-use disorder
por: Rosic, Tea, et al.
Publicado: (2020)

A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder
por: Dennis, Brittany B., et al.
Publicado: (2020)

Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences
por: Chawar, Caroul, et al.
Publicado: (2021)

Sensitivity and specificity of self-reported psychiatric diagnoses amongst patients treated for opioid use disorder
por: Leung, Kelly, et al.
Publicado: (2021)

Evaluation of BDNF as a Biomarker for Impulsivity in a Psychiatric Population
por: Pasyk, Stanislav, et al.
Publicado: (2020)

Children and Youth Who Use Cannabis for Pain Relief: Benefits, Risks, and Perceptions
por: Woo, Julia J, et al.
Publicado: (2020)

Sociodemographic characteristics of patients with children in a methadone maintenance program: a cross-sectional study
por: Luo, Candice, et al.
Publicado: (2019)

Trauma and post-traumatic stress disorder in patients treated for opioid use disorder: findings from a 12-month cohort study
por: Rosic, Tea, et al.
Publicado: (2021)

Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol
por: Sanger, Nitika, et al.
Publicado: (2018)

National suicide management guidelines with family as an interv’ention and suicide mortality rates: a systematic review protocol
por: Panesar, Balpreet, et al.
Publicado: (2020)

The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study
por: Rosic, Tea, et al.
Publicado: (2017)

COVID-19 retracted publications on retraction watch: A systematic survey of their pre-prints and citations
por: Syed, Zainab, et al.
Publicado: (2023)

Adverse outcomes associated with opioid prescription for acute low back pain: a systematic review protocol
por: Mouravska, Natalia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_90ebr4d9u8cpd854gbr5f41o1b